초록 ▼

The invention relates to a method of treating and preventing ageing of the pilosebaceous unit and/or alopecia in human through the administration of taurine and/or hypotaurine and/or the acceptable salts thereof in an oral composition. Specifically, the invention relates to a method of treating and

The invention relates to a method of treating and preventing ageing of the pilosebaceous unit and/or alopecia in human through the administration of taurine and/or hypotaurine and/or the acceptable salts thereof in an oral composition. Specifically, the invention relates to a method of treating and preventing miniaturization of the hair follicle. The invention also relates to the use of polyphenols to achieve these same ends. Finally, the invention relates to oral compositions that include polyphenols or taurine and/or hypotaurine and/or the acceptable salts thereof as active ingredients.

대표청구항 ▼

1. A method of treating miniaturization of the hair follicle, comprising administering to a human being an oral composition comprising at least one of taurine, hypotaurine, salts of taurine and salts of hypotaurine, and at least one polyphenol, said polyphenol being selected from the group consistin

1. A method of treating miniaturization of the hair follicle, comprising administering to a human being an oral composition comprising at least one of taurine, hypotaurine, salts of taurine and salts of hypotaurine, and at least one polyphenol, said polyphenol being selected from the group consisting of procyanidins, proanthocyanidins, a mixture of catechin monomers with procyanidin oligomers, and mixtures thereof, a weight ratio of polyphenol/taurine being at least 0.5, in an amount effective for treating miniaturization of the hair follicle; wherein the taurine, hypotaurine, and salts thereof are the sole active amino acid. 2. The method as claimed in claim 1, wherein the method treats impairment of the connective tissue of the hair follicle. 3. The method as claimed in claim 1, wherein the method treats impairment of the hair follicle induced by rigidification of the connective sheath. 4. The method as claimed in claim 1, wherein the method treats impairment of the hair follicle induced by excessive crosslinking and/or synthesis of natural collagens. 5. The method as claimed in claim 1, wherein the method regulates the metabolism and structure of collagens in perifollicular skin tissue. 6. The method as claimed in claim 1, wherein the method regulates the metabolism and structure of collagens in the connective sheath of the hair follicle. 7. The method as claimed in claim 1, wherein an amount of taurine is between 0.5 and 4000 mg/day in the form of taurine and/or hypotaurine and/or salts thereof. 8. The method as claimed in claim 1, wherein an amount of taurine is between 10 and 500 mg/day in the form of taurine and/or hypotaurine and/or salts thereof. 9. The method as claimed in claim 1, wherein an amount of taurine is between 50 and 150 mg/day in the form of taurine and/or hypotaurine and/or salts thereof. 10. The method as claimed in claim 1, wherein the salts of taurine and/or hypotaurine are the magnesium, manganese, iron II or zinc salts. 11. The method as claimed in claim 1, wherein the oral composition further comprises at least one fatty acid. 12. The method as claimed in claim 11, wherein the fatty acid is selected from the group consisting of n-6 and n-3 essential polyunsaturated fatty acids containing between 18 and 22 carbon atoms, esters thereof, and mixtures thereof. 13. The method as claimed in claim 11, wherein the fatty acid is selected from the group consisting of linoleic acid, γ-linolenic acid, linolenic acid, stearidonic acid, crocetin, 5,8,11,14-eicosatetraenoic acid, and mixtures thereof. 14. The method as claimed in claim 11, wherein the daily dose of the fatty acid is between 0.5 and 3500 mg/day. 15. The method as claimed in claim 11, wherein the fatty acid is at least one n-6 fatty acid in an amount of 0.5 to 2600 mg/day. 16. The method as claimed in claim 11, wherein the fatty acid is at least one n-3 fatty acid in an amount of 0.5 to 2500 mg/day. 17. The method as claimed in claim 1, wherein the oral composition is in the form of a food supplement. 18. The method as claimed in claim 1, wherein the daily dose of the polyphenol is between 0.5 and 2000 mg/day. 19. The method as claimed in claim 1, wherein the daily dose of the polyphenol is from about 0.5 to 1000 mg/day. 20. The method as claimed in claim 1, wherein the oral composition further comprises at least one supplement selected from the group consisting of vitamins C and E, zinc and salts thereof, selenium, and carotenoids. 21. The method as claimed in claim 1, wherein the polyphenol/taurine weight ratio is greater than or equal to 0.75. 22. The method as claimed in claim 1, wherein said composition comprises 0.01% to 30% by weight of taurine and/or hypotaurine and/or salts thereof, in combination with 0.1% to 50% by weight of extracts comprising said at least one polyphenol. 23. The method as claimed in claim 1, wherein said composition is free of vitamin C. 24. The method as claimed in claim 1, wherein said at least one polyphenol is mixture of catechin monomers with procyanidin oligomers, in an amount effective for treating miniaturization of the hair follicle. 25. A cosmetic process for treating miniaturization of the hair follicle via the oral administration of an oral composition comprising taurine and/or hypotaurine and/or acceptable salts thereof; and at least one polyphenol, said polyphenol being selected from the group consisting of procyanidins, proanthocyanidins, a mixture of catechin monomers with procyanidin oligomers, and mixtures thereof, a weight ratio of polyphenol/taurine being at least 0.5; wherein the taurine and/or hypotaurine and/or acceptable salts thereof are the only active amino acid administered. 26. The process as claimed in claim 25, in which the taurine, hypotaurine and/or acceptable salts thereof is (are) administered at a dose of from 0.5 to 4000 mg per day of taurine. 27. The process as claimed in claim 25, in which the taurine, hypotaurine and/or acceptable salts thereof is (are) used in combination with at least one supplement selected from the group consisting of zinc, fatty acids, vitamin C, vitamin E, and carotenoids. 28. The method as claimed in claim 25, wherein said at least one polyphenol is a mixture of catechin monomers with procyanidin oligomers in an amount effective for treating miniaturization of the hair follicle. 29. A cosmetic process for treating disorders of a pilosebaceous unit via oral administration of at least one fatty acid, at least one polyphenol or an extract comprising the same, said polyphenol being selected from the group consisting of procyanidins, proanthocyanidins, a mixture of catechin monomers with procyanidin oligomers, and mixtures thereof, in combination with at least one of taurine, hypotaurine, salts of taurine and salts of hypotaurine, a weight ratio of polyphenol/taurine being at least 0.5, wherein the taurine, hypotaurine, and salts thereof are the sole active amino acid. 30. The process as claimed in claim 29, in which the taurine, hypotaurine or acceptable salts thereof is (are) administered at a dose of from 0.5 to 4000 mg/day, as taurine equivalent, and the at least one fatty acid is administered at a dose of from 0.5 to 5400 mg/day, and the at least one polyphenol is administered at a dose of from 0.5 to 2000 mg/day. 31. A composition for oral absorption, comprising: a total amount of at least 0.05% to 80% by weight of at least one of taurine, hypotaurine, salts of taurine and salts of hypotaurine as an active agent, the salts being acceptable for oral absorption, at least one polyphenol, said polyphenol being selected from the group consisting of procyanidins, proanthocyanidins, a mixture of catechin monomers with procyanidin oligomers, and mixtures thereof, a weight ratio of polyphenol/taurine being at least 0.5, and an excipient, said composition being free of vitamin C, wherein the taurine, hypotaurine, and salts thereof are the sole active amino acid. 32. The composition as claimed in claim 31, further comprising at least one fatty acid and/or a salt thereof acceptable in an oral composition. 33. The composition as claimed in claim 32, wherein said composition comprises from 0.01% to 10% by weight of said at least one polyphenol and/or 0.1% to 10% by weight of said at least one fatty acid. 34. The composition as claimed in claim 33, further comprising at least one compound selected from the group consisting of vitamin E, zinc, zinc salts, selenium and carotenoids. 35. The composition as claimed in claim 34, wherein the compound comprises at least one carotenoid selected from the group consisting of β-carotene, lycopene, zeaxanthin, and lutein. 36. The composition as claimed in claim 33, wherein said composition comprises an excipient that is acceptable for a food supplement in the form of a sugarcoated tablet, a gel capsule, a gel, an emulsion, a tablet, a wafer capsule, a drinkable ampule, a dilutable or nondilutable powder, a dietary bar or an enriched food. 37. The composition as claimed in claim 32, wherein said composition comprises 0.01% to 30% by weight of taurine and/or hypotaurine and/or acceptable salts thereof, in combination with 0.1% to 50% by weight of extracts comprising said at least one polyphenol. 38. The composition as claimed in claim 31, wherein said composition is a food supplement. 39. The composition as claimed in claim 31, wherein the polyphenol/taurine weight ratio is greater than or equal to 0.75. 40. The composition as claimed in claim 31, wherein the polyphenol/taurine weight ratio is greater than or equal to 1. 41. A composition for oral absorption, comprising: at least one polyphenol selected from the group consisting of procyanidins, proanthocyanidins, a mixture of catechin monomers with procyanidin oligomers, and mixtures thereof;a fatty acid selected from the group consisting of n-6 and n-3 essential polyunsaturated fatty acids containing between 18 and 22 carbon atoms, esters thereof, and mixtures thereof; andat least one of taurine, hypotaurine, salts of taurine and salts of hypotaurine, the salts being acceptable for oral absorption, a weight ratio of polyphenol/taurine being at least 0.5;wherein the taurine, hypotaurine, and salts thereof are the sole active amino acid. 42. The composition as claimed in claim 41, wherein said composition comprises catechins. 43. The composition as claimed in claim 42, wherein said composition comprises 0.01% to 30% by weight of said taurine and/or hypotaurine and/or acceptable salts thereof; in combination with 0.1% to 25% by weight of said catechins. 44. A composition for oral absorption, comprising 0.01% to 30% by weight of at least one of taurine, hypotaurine, salts of taurine and salts of hypotaurine, 0.01% to 10% by weight of fatty acids, and at least one polyphenol, said polyphenol being selected from the group consisting of procyanidins, proanthocyanidins, a mixture of catechin monomers with procyanidin oligomers, and mixtures thereof, a weight ratio of polyphenol/taurine being at least 0.5, wherein the at least one of taurine, hypotaurine, and salts thereof are the sole active amino acid.